Holen Sie sich die Stockscreener-App
473.42
1.48%
-7.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Vanguard Group Inc. Lowers Position in United Therapeutics Corporation $UTHR - MarketBeat
Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Insider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 8,300 Shares of Stock - MarketBeat
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight (2026-02-19) - Seeking Alpha
AnaptysBio (ANAB) to Release Quarterly Earnings on Thursday - Defense World
Cabot Corporation (NYSE:CBT) Given Average Rating of “Hold” by Analysts - Defense World
Vertex Casgevy Rollout Tests Gene Editing Role In Vertex Earnings Story - simplywall.st
Oppenheimer & Co. Inc. Takes $407,000 Position in BridgeBio Pharma, Inc. $BBIO - Defense World
Shell Asset Management Co. Decreases Position in United Therapeutics Corporation $UTHR - Defense World
Market Today: Moderna rebounds; oil and gold jump - GuruFocus
Medicenna Therapeutics Announces Participation in Upcoming Conferences - GlobeNewswire
United Therapeutics (UTHR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
8,211 Shares in United Therapeutics Corporation $UTHR Bought by First National Bank of Omaha - MarketBeat
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
UBS reiterates Buy on United Therapeutics stock ahead of trials By Investing.com - Investing.com Nigeria
UBS reiterates Buy on United Therapeutics stock ahead of trials - Investing.com
MidWestOne Financial Group Inc. Raises Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Envestnet Asset Management Inc. Sells 15,252 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Can United Therapeutics Corporation navigate macro headwindsTrade Risk Summary & High Return Stock Watch Alerts - mfd.ru
Market Fear: Can FingerMotion Inc continue delivering strong returnsJuly 2025 Closing Moves & Expert Curated Trade Ideas - baoquankhu1.vn
Assessing United Therapeutics (UTHR) Valuation As Long Term Returns Contrast With Softer Recent Momentum - Yahoo Finance
LSV Asset Management Sells 177,913 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corp. (NASDAQ:UTHR) Passes the "Caviar Cruise" Quality Investing Screen - ChartMill
United Therapeutics sets Feb. 25 date for 2025 earnings webcast - Stock Titan
United Therapeutics (NASDAQ:UTHR) COO Sells $10,679,625.00 in Stock - MarketBeat
United Therapeutics Nears Key Data Milestone With Completed TETON-1 IPF Trial - TipRanks
United Therapeutics Corporation $UTHR Shares Sold by Ashton Thomas Private Wealth LLC - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Cuts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Assessing United Therapeutics (UTHR) Valuation After Positive MiroliverELAP Phase 1 Safety And Survival Data - simplywall.st
Aug Fed Impact: Will United Therapeutics Corporation benefit from government policyJuly 2025 Rallies & Risk Controlled Daily Plans - baoquankhu1.vn
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
United Therapeutics Corporation $UTHR Shares Purchased by AE Wealth Management LLC - MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring A 13% Upside Potential - DirectorsTalk Interviews
Bank of New York Mellon Corp Sells 11,016 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Summit Global Investments Sells 3,327 Shares of United Therapeutics Corporation $UTHR - MarketBeat
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack - Yahoo Finance
A Look Back at Therapeutics Stocks' Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack - Finviz
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) - Finviz
Mutual of America Capital Management LLC Acquires 4,036 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Sells 13,401 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Strs Ohio Has $4.22 Million Stake in United Therapeutics Corporation $UTHR - MarketBeat
What's Going On With United Therapeutics Stock Monday?United Therapeutics (NASDAQ:UTHR) - Benzinga
United Therapeutics reports positive phase 1 results for bioengineered liver By Investing.com - Investing.com Canada
How Investors May Respond To United Therapeutics (UTHR) Positive Early Data For Bioengineered Liver Support Device - Yahoo Finance
United Therapeutics reports positive phase 1 results for bioengineered liver - Investing.com
Retirement Systems of Alabama Sells 18,709 Shares of United Therapeutics Corporation $UTHR - MarketBeat
World’s first FDA-cleared bioengineered liver trial meets survival goal - Stock Titan
United Therapeutics Reports Early Success For External Liver Support In Acute Failure - Sahm
The Best Pharma Stock I’ve Ever Seen - Nanalyze
United Therapeutics appoints biomedical research leader to board By Investing.com - Investing.com Nigeria
United Therapeutics Appoints Kevin J. Tracey To Board - citybiz
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Board of Directors, Effective January 21, 2026 - marketscreener.com
United Therapeutics appoints biomedical research leader to board - Investing.com
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - United Therapeutics Investor Relations
Element Squared LLC Buys 5,027 Shares of United Therapeutics Corp (UTHR) - GuruFocus
Marquette Asset Management, LLC Buys 1 Shares of United Therapeutics Corp (UTHR) - GuruFocus
United Therapeutics Corporation (UTHR): A Bull Case Theory - Finviz
0.38%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):